
Senator · AK · R
Current term Jan 3, 2023 – Jan 3, 2029 · In the Senate since Jan 7, 2003
Official websiteContact formBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 27, 2026. Only the current version of each report is used.
37,853 report citations, newest first.
NATIONAL ASSOCIATION OF REALTORS · lobbying firm or registrant: NATIONAL ASSOCIATION OF REALTORS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$27,400,000
Spent on own lobbying
CitesS. 1515· this member:Cosponsored
…ing Affordability and Availability H.R.1 One Big Beautiful Bill Act H.R. 1340/ S. 3332 More Homes on the Market Act H.R. 2854 Neighborhood Homes Investment Act S.1515/H.R.2725 -Affordable Housing Credit Improvement Act H.R. 7349 Time to Heal Act H.R. 7185 Home Savings Act H.R. 7051 Investing in the American Dream Act H.R. 74…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF REALTORS · lobbying firm or registrant: NATIONAL ASSOCIATION OF REALTORS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$27,400,000
Spent on own lobbying
CitesS. 4942· this member:Cosponsored
Access to Banking for Cannabis Businesses S. 4942/H.R. 9471 SAFE/SAFER Banking Act Banking Regulations S.1467/H.R.2808 - Homebuyers Privacy Protection Act H.R. 5402/S. 1465 Credit Access and Inclusion Act H.R.…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$1,160,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
AD&C Lending, FHA Reform, Affordable Housing Reform, GSE Reform, S. 1071 The National Defense Authorization Act for FY 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$1,160,000
Spent on own lobbying
CitesH.R. 5371· this member:Recorded votes on 23 roll calls
…gencies Appropriations; Department of the Interior, Environment, and Related Agencies Appropriations; Financial Services and General Government Appropriations; H.R. 5371, the Continuing Appropriations Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Housing
$1,160,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
…using Supply and Innovation Frameworks Act, the ROAD to Housing Act, H.R. 5878 the HOME Reform Act, S. 1071 The National Defense Authorization Act for FY 2026, H.R. 6644 The 21st Century ROAD to Housing Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Housing
$1,160,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…orrower Protection Act, Choice in Affordable Housing Act, Housing Supply and Innovation Frameworks Act, the ROAD to Housing Act, H.R. 5878 the HOME Reform Act, S. 1071 The National Defense Authorization Act for FY 2026, H.R. 6644 The 21st Century ROAD to Housing Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF HOME BUILDERS · lobbying firm or registrant: NATIONAL ASSOCIATION OF HOME BUILDERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Disaster Planning/Emergencies
$1,160,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…ng Codes Flexibility, H.R.501/S.333 (the Promoting Resilient Buildings Act), H.R. 4669 (FEMA Act of 2025), H.R.1105 (The Disaster Resiliency and Coverage Act), S. 1071 (The National Defense Authorization Act for FY 26)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SOLSTICE ADVANCED MATERIALS INC · lobbying firm or registrant: SOLSTICE ADVANCED MATERIALS INC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$950,000
Spent on own lobbying
CitesS. 2431· this member:Sponsored
…opriations for protective armor FY26 Interior and Environment Appropriations: EPA budget related to Significant New Alternatives Program and Montreal Protocol (S.2431/H.R.4754) FY26 State Department, Foreign Operations and Related Appropriations: State Department budget related to Montreal Protocol (H.R.4779) Defense Product…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
APTS ACTION INC · lobbying firm or registrant: APTS ACTION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$300,000
Spent on own lobbying
CitesH.R. 4· this member:Recorded votes on 21 roll calls
Funding for public broadcasting's public safety work Funding for public broadcastings infrastructure H.R. 4, the Rescissions Act of 2025. Issue: Public broadcasting rescissions Cancelling of previously appropriated Ready To Learn Funding Freezing of previously approp…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
EQUIFAX · lobbying firm or registrant: THOLOS GOVERNMENT RELATIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$70,000
Paid to lobbying firm
CitesS. 1892· this member:Sponsored
H.R. 909/S. 1892-Crime Victims Fund Stabilization Act of 2025; Issues related to funding for the Victims of Crime Act (VOCA)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Ac…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded votes on 4 roll calls
H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103) Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law 119-…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 6938· this member:Recorded votes on 3 roll calls
…man Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesH.R. 7148· this member:Recorded votes on 8 roll calls
…on Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (Public Law 117-169) implementation policy issues Government funding…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 1071· this member:Recorded votes on 3 roll calls
…t; and Interior and Environment Appropriations Act, 2026 (Public Law 119-74) S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: Nation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
…Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authoriza…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$7,040,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
…ar 2026 (Public Law 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: ORPHAN Cures Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 4189· this member:Cosponsored
…Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act S. 3794: SAFE Drugs Act of 2026 S. 4189: INSULIN Act of 2026 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5244: SUSTAIN 340B Act H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 946: O…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination A…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$7,040,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
H.R. 1: One Big Beautiful Bill Act (Public Law 119-21) H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act H.R. 10628: Biosimilars Access and Aff…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STATE FEDERAL STRATEGIES ON BEHALF OF HFIAW LABOR MANAGEMENT COOPERATIVE TRUST · lobbying firm or registrant: MISSY EDWARDS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Environment/Superfund
$30,000
Paid to lobbying firm
CitesS. 4312· this member:Cosponsored
H.R. 3474, The Federal Mechanical Insulation Act S. 4312, The Federal Mechanical Insulation Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STATE FEDERAL STRATEGIES ON BEHALF OF HFIAW LABOR MANAGEMENT COOPERATIVE TRUST · lobbying firm or registrant: MISSY EDWARDS STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$30,000
Paid to lobbying firm
CitesS. 4312· this member:Cosponsored
H.R. 3474, The Federal Mechanical Insulation Act S. 4312, The Federal Mechanical Insulation Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE OHIO STATE UNIVERSITY · lobbying firm or registrant: THE OHIO STATE UNIVERSITY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Sports/Athletics
$90,115
Spent on own lobbying
CitesS. 4668· this member:Recorded votes on 11 roll calls
- General issues related to Name, Image, Likeness in collegiate athletics. - S. 4668, the Protect College Sports Act; All provisions.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CENTER FOR AI SAFETY ACTION FUND, INC. · lobbying firm or registrant: CENTER FOR AI SAFETY ACTION FUND, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · amended · posted Oct 20, 2026 · issue area: Defense
$60,000
Spent on own lobbying
CitesS. 2296· this member:Recorded votes on 12 roll calls
S. 2296: National Defense Authorization Act for Fiscal Year 2026; provisions related to artificial intelligence policy
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing